aana glp-1 guidelines Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Receptor Agonists: A Multidisciplinary Expert Consensus AANA Publishes Considerations for Anesthesia

6 : CD008955

The second major player is a pill version of a weight-loss medication you likely already know: Wegovy

1996, Life Sciences)

Ezetimibe This drug is sold under the trade names Zetia or Ezetrol and is also combined with the statin drug simvastatin and sold as Vytorin or Inegy

Dosing typically begins at a lower dose, suggested initiation of 4 units (0.04 mL) weekly for the first 4 weeks, then escalates according to a titration schedule: Weeks 1-4: Inject 4 units (0.04 mL) one time per week Weeks 5-8: Inject 8 units (0.08 mL) one time per week Weeks 9-12: Inject 18 units (0.18 mL) one time per week Weeks 13-16: Inject 30 units (0.3 mL) one time per week Week 16+: Inject 44 units (0.44 mL) one time per week Dosing may deviate from this pattern to accommodate patient-specific needs

In research models, Tesamorelin stimulates pulsatile GH release from the anterior pituitary with a duration of action extending beyond native GHRH due to its structural modifications